Discover
INZY
Inozyme Pharma, Inc.
4.00
undefined x undefined
undefined x undefined
bid
ask
+
4.00
0.00%
07:00 PM
| Ytd | 44.40% | |
| 1y | -10.31% |
day range
52 week range
| Open | Prev Close | Low | High | Mkt Cap | N/A | ||||
| Vol | 0.00 | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -1.86 |
| Beta | 1.54 | Short Ratio | 7.59 | Inst. Own | 98.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 19.56 |
| Income Statement | |||
| Operating Expenses | 27.69M | ||
| Research and Development Expense | 20.38M | ||
| Selling, General and Administrative Expense | 5.41M | ||
| Operating Income | -27.69M | ||
| Interest Expense | 1.41M | ||
| Net Income | -28.04M | ||
| Net Income Common Stock | -28.04M | ||
| Net Income Common Stock (USD) | -28.04M | ||
| Consolidated Income | -28.04M | ||
| Earnings per Basic Share | -0.44 | ||
| Earnings per Basic Share (USD) | -0.44 | ||
| Earnings per Diluted Share | -0.44 | ||
| Earning Before Interest & Taxes (EBIT) | -26.63M | ||
| Earning Before Interest & Taxes (USD) | -26.63M | ||
| Weighted Average Shares | 64.28M | ||
| Weighted Average Shares Diluted | 64.28M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.16M | ||
| Cash and Equivalents (USD) | 26.16M | ||
| Investments | 58.93M | ||
| Investments Current | 58.93M | ||
| Current Assets | 93.64M | ||
| Property, Plant & Equipment Net | 1.02M | ||
| Total Assets | 95.16M | ||
| Debt Current | 26.37M | ||
| Total Debt | 46.95M | ||
| Current Liabilities | 42.78M | ||
| Debt Non-Current | 20.59M | ||
| Total Liabilities | 63.37M | ||
| Accumulated Retained Earnings (Deficit) | -415.99M | ||
| Accumulated Other Comprehensive Income | -5.00K | ||
| Shareholders Equity | 31.80M | ||
| Shareholders Equity (USD) | 31.80M | ||
| Assets Non-Current | 1.53M | ||
| Total Debt (USD) | 46.95M | ||
| Liabilities Non-Current | 20.59M | ||
| Trade and Non-Trade Payables | 3.67M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 328.00K | ||
| Net Cash Flow from Financing | 228.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.76M | ||
| Issuance (Purchase) of Equity Shares | 228.00K | ||
| Net Cash Flow from Investing | 33.68M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 33.68M | ||
| Net Cash Flow from Operations | -29.15M | ||
| Effect of Exchange Rate Changes on Cash | 2.00K | ||
| Share Based Compensation | 1.86M | ||